Solco Biomedical Company India Private Limited appears in FDA device records as the applicant for spinal hardware under the 4CIS name and related system names. The supplied filings cover intervertebral body fusion devices regulated under 21 CFR 888.3080 and thoracolumbosacral pedicle screw systems under 21 CFR 888.3070, both Class II. The most recent record is a traditional 510(k) with a summary, decided substantially equivalent on November 6, 2026. Earlier clearances in the same name date to 2020 and 2022, and a 2024 letter covers pedicle screw systems. [1][3][5][8]

The 2026 Blue Dolphin clearance

K252865 covers the 4CIS BLUE DOLPHIN CAGE SYSTEM, received September 9, 2025 and decided November 6, 2026 with decision code SESE, meaning substantially equivalent. The record lists product code MAX, advisory committee Orthopedic, regulation 888.3080, device class 2, and a traditional clearance with a summary rather than a third-party review. The device name in the openFDA fields is Intervertebral Fusion Device With Bone Graft, Lumbar. [1]

The filing address on K252865 is in Ahmedabad, Gujarat, with Darshak Shah listed as contact. That address is a correspondence address in a regulatory filing and is not treated here as a verified corporate headquarters. The same record carries a large set of establishment identifiers and registration numbers in its openFDA block, which reflect database cross-references rather than a verified facility list for this applicant. [1]

Earlier 4CIS cage and screw clearances

K213653, decided December 19, 2022, names the 4CIS BLACK MARLIN PLIF CAGE SYSTEM and 4CIS DOLPHIN TLIF CAGE SYSTEM under regulation 888.3080, Class II, product code MAX. The letter is addressed to Darshak Shah as Director at the Ahmedabad address and identifies K221844, the TDM Lumbar Interbody Fusion Cage System from TDM Co., as the primary predicate. [3]

K232607, dated February 27, 2024, covers the 4CIS SARA SPINE SYSTEM, 4CIS VERTU SPINE SYSTEM, 4CIS WILL PEDICLE SCREW SYSTEM, aBle SPINAL FIXATION SYSTEM and aBle Xt SPINAL FIXATION SYSTEM under 21 CFR 888.3070, Thoracolumbosacral Pedicle Screw System, Class II, product code NKB. The letter address is Survey No.1540, Village-Rajpur, Kadi, Gujarat, again a filing address rather than a confirmed headquarters. [5]

K202498, dated December 30, 2020, covers the 4CIS SARA Spine System and 4CIS VERTU Spine System under 888.3070, Class II, product code NKB. Its predicate table lists K102458, the 4CIS SOLAR Spine System from Solco Biomedical Co., Ltd.-Korea, as primary and K030383, the Moss Miami Spinal System from DePuy AcroMed, as reference. The device description states a top-loading posterior spinal fixation system with pedicle screws, rods, nuts, transverse link and associated instruments. [8]

What the supplied collection shows

The MedtechLedger snapshot links one 510(k) record to this company, K252865, with a decision count of one substantially equivalent decision and a matching sample decision count. That single linked record is the basis for the counts here and does not represent total company sales, total portfolio or safety performance. A separate third-party page states three 510(k) clearances as of November 17, 2026, with the November 6, 2026 Blue Dolphin clearance as the most recent; that count is attributed to its publisher. [1][9]

A registration and listing query returned 117 results under the searched name, with a listed product described as an intervertebral fusion device with bone graft, cervical, product code ODP, regulation 888.3080, class 2, and a contact address on Ashram Road, Ahmedabad. The same result set includes proprietary names such as MATISSE ACIF Cage, Titanium-PEEK. These listing entries are database matches to the search term and are not presented as a verified product roster for this applicant. [6]

Applicant identity and limits of the record

The FDA letters name Solco Biomedical Company India Private Limited as the applicant, with Darshak Shah as Director. The 2020 predicate table separately names Solco Biomedical Co., Ltd.-Korea as manufacturer of the 4CIS SOLAR Spine System, which shows a Korean entity in the predicate chain; the public documents do not establish a parent, subsidiary or brand relationship between the two, so none is asserted. [5][8]

A third-party company page describes the firm with language about generic drug making and a pharmaceutical parent, and notes that some facts were labelled by a language model. Those descriptions are not corroborated by the FDA filings supplied and are not adopted here. No website, customer list, commercial availability, clinical performance or certification is documented in the public documents, and those points remain unknown. [9]